A Double Blind, Randomized, Placebo Controlled Clinical Study To Evaluate The Efficacy And Safety Of Tfn34 Tablets For Individuals With Subclinical And Clinical Hypothyroidism. Journal of Pharmaceutical Negative Results [Internet]. 2022 Dec. 31 [cited 2026 Jun. 14];:8599-614. Available from: https://www.pnrjournal.com/index.php/home/article/view/6329